TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06664775: A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery

Sponsor: Corza Medical GmbH · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 116 pts

Competing Trials Overlap

7 Active Trials

Excess Burn Exposure

$1,791,472

Rescue Site Savings

+$1,178,600

Unlock Full NCT06664775 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06664775 Rescue Dossier →